Crystallisation process for 1-(beta-D-glucopyranosyl)-4-methyl-3- [5-(4-fluorophenyl)-2-thienylmethyl] benzene

Details for Australian Patent Application No. 2010270202 (hide)

Owner Janssen Pharmaceutica NV

Inventors Rammeloo, Thomas Joachim Landewald; De Keyser, Ruben; Schildermans, Gustaaf Jozef Petrus

Agent Shelston IP

Pub. Number AU-A-2010270202

PCT Pub. Number WO2011/003976

Priority 09165125.7 10.07.09 EP

Filing date 8 July 2010

Wipo publication date 13 January 2011

International Classifications

C07D 309/10 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2011/003976 Priority application(s): WO2011/003976

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010270221-Product for the storage of freeze-dried lactic acid bacteria mixed with a powder for an oral rehydration solution

2010270201-Novel architecture of a compensator for power factors and harmonics for a power distribution network